NR3C1 and tuberculosis: Even though MPA and NET-A are designed to act via the progesterone receptor (PR), MPA, unlike NET-A, acts as an agonist for the glucocorticoid receptor (GR) [7–10], the activation of which is a well-known risk factor and trigger for TB reactivation [11, 12].